Based on the key indicators related to Pmv Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, Pmv Pharmaceuticals is not in a good financial situation at this time. It has a very high odds of going through financial crisis in April. At this time, Pmv Pharmaceuticals' Total Current Assets are relatively stable compared to the past year. As of 03/22/2025, Accumulated Other Comprehensive Income is likely to grow to about 145.9 K, while Net Tangible Assets are likely to drop slightly above 175.4 M. Key indicators impacting Pmv Pharmaceuticals' financial strength include:
The essential information of the day-to-day investment outlook for Pmv Pharmaceuticals includes many different criteria found on its balance sheet. An individual investor should monitor Pmv Pharmaceuticals' cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Pmv Pharmaceuticals.
Pmv Pharmaceuticals competes with MediciNova, Pharvaris, PepGen, Anebulo Pharmaceuticals, and Acrivon Therapeutics,. PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Cranbury, New Jersey. Pmv Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 54 people.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
The reason investors look at the income statement is to determine what Pmv Pharmaceuticals' earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
Comparative valuation techniques use various fundamental indicators to help in determining Pmv Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Pmv Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Pmv Pharmaceuticals competition to find correlations between indicators driving Pmv Pharmaceuticals's intrinsic value. More Info.
Pmv Pharmaceuticals is regarded third in return on equity category among its peers. It is regarded fifth in return on asset category among its peers . At this time, Pmv Pharmaceuticals' Return On Equity is relatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Pmv Pharmaceuticals by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Pmv Pharmaceuticals Systematic Risk
Pmv Pharmaceuticals' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Pmv Pharmaceuticals volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Pmv Pharmaceuticals correlated with the market. If Beta is less than 0 Pmv Pharmaceuticals generally moves in the opposite direction as compared to the market. If Pmv Pharmaceuticals Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Pmv Pharmaceuticals is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Pmv Pharmaceuticals is generally in the same direction as the market. If Beta > 1 Pmv Pharmaceuticals moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Pmv Pharmaceuticals Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Pmv Pharmaceuticals' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Pmv Pharmaceuticals growth as a starting point in their analysis.
Pmv Pharmaceuticals March 22, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Pmv Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Pmv Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Pmv Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Pmv Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Pmv Pharmaceuticals's daily price indicators and compare them against related drivers.
When running Pmv Pharmaceuticals' price analysis, check to measure Pmv Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pmv Pharmaceuticals is operating at the current time. Most of Pmv Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Pmv Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pmv Pharmaceuticals' price. Additionally, you may evaluate how the addition of Pmv Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.